Amphastar Pharmaceuticals, Inc.
AMPH
$29.15
$0.341.18%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.98% | 5.26% | |||
| Total Other Revenue | -119.00% | -20.33% | |||
| Total Revenue | -2.45% | 4.84% | |||
| Cost of Revenue | 11.88% | 2.34% | |||
| Gross Profit | -15.00% | 7.12% | |||
| SG&A Expenses | -1.91% | 6.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.38% | 5.50% | |||
| Operating Income | -20.87% | 3.32% | |||
| Income Before Tax | -7.80% | -5.10% | |||
| Income Tax Expenses | -17.31% | -41.00% | |||
| Earnings from Continuing Operations | -6.10% | 6.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.10% | 6.54% | |||
| EBIT | -20.87% | 3.32% | |||
| EBITDA | -16.85% | 3.05% | |||
| EPS Basic | -4.83% | 7.17% | |||
| Normalized Basic EPS | -6.56% | -4.55% | |||
| EPS Diluted | -5.19% | 6.85% | |||
| Normalized Diluted EPS | -6.80% | -4.76% | |||
| Average Basic Shares Outstanding | -1.33% | -0.58% | |||
| Average Diluted Shares Outstanding | -1.06% | -0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
